Biofrontera Inc. - Common Stock (NQ:BFRI)

0.8909 -0.1191 (-11.79%)

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Biofrontera Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Biofrontera (NASDAQ:BFRI) Passes Minervini Trend Template With High-Growth Momentum ↗

September 09, 2026

Via Chartmill

Biofrontera (BFRI) Q2 2026 Earnings Call Transcript ↗

August 20, 2026

Gross margins expanded 920 basis points as restructured costs offset ITC lamp restrictions.

Via The Motley Fool

Topics Earnings

Biofrontera (BFRI) Q1 2026 Earnings Transcript ↗

June 02, 2026

Biofrontera (BFRI) Q1 2026 Earnings Transcript

Via The Motley Fool

Topics Intellectual Property

Biofrontera Inc. (NASDAQ:BFRI) Reports Q1 2026 Revenue and EPS Miss, Stock Falls in Pre-Market ↗

May 14, 2026

Via Chartmill

Earnings Scheduled For November 12, 2025 ↗

November 12, 2025

Via Benzinga

A Look at Biofrontera's Upcoming Earnings Report ↗

August 12, 2025

Via Benzinga

An Overview of Biofrontera's Earnings ↗

May 14, 2025

Via Benzinga

Earnings Scheduled For November 13, 2024 ↗

November 13, 2024

Via Benzinga

Biofrontera (BFRI) Q4 2025 Earnings Transcript ↗

March 19, 2026

Biofrontera (BFRI) Q4 2025 Earnings Transcript

Via The Motley Fool

Topics Intellectual Property

Get insights into the top gainers and losers of Thursday's after-hours session. ↗

January 01, 2026

Via Chartmill

Wondering what's happening in today's after-hours session? ↗

December 31, 2025

Via Chartmill

Earnings Outlook For Biofrontera ↗

November 12, 2024

Via Benzinga

Biofrontera Earnings Preview ↗

November 11, 2025

Via Benzinga

EXCLUSIVE: Pelthos Secures Rights To Antimicrobial Drug, Raises $18 Million To Support Commercial Launch ↗

November 07, 2025

Pelthos Therapeutics acquires U.S. rights to Xepi Cream and raises $18 million to fund its relaunch and expand dermatology product offerings.

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

September 08, 2025

Via Benzinga

Biofrontera Q2 Revenue Jumps 15% ↗

August 14, 2025

Via The Motley Fool

Topics World Trade

Biofrontera Revenue Jumps 15% in Q2 ↗

August 13, 2025

Via The Motley Fool

Topics Intellectual Property

Earnings Scheduled For August 13, 2025 ↗

August 13, 2025

Via Benzinga

Get insights into the top gainers and losers of Monday's pre-market session. ↗

June 30, 2025

Discover the top movers in Monday's pre-market session and stay informed about market dynamics.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 16, 2025

Via Benzinga

Why Quantum Computing Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket ↗

May 16, 2025

Via Benzinga

Earnings Scheduled For May 15, 2025 ↗

May 15, 2025

Via Benzinga

Biofrontera Inc. to Report First Quarter FY 2025 Financial Results on May 15, 2025

May 06, 2025

Via ACCESS Newswire

Earnings Scheduled For March 21, 2025 ↗

March 21, 2025

Via Benzinga

Why Stitch Fix Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket ↗

December 11, 2024

Via Benzinga

Biofrontera Inc. to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

December 03, 2024

Via ACCESSWIRE

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 01, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 01, 2024

Via Benzinga

Biofrontera Inc. to Report Third Quarter Financial Results on November 13, 2024

November 01, 2024

Via ACCESSWIRE

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 31, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.